Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1194 of 5804
-
New study tests apremilast for psoriasis relief
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of Apremilast tablets in patients with psoriasis over 32 weeks, through a multicenter, single-arm, open-label, phase 4 clinical trial.
Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for CRPS sufferers: brain zaps and therapy combo put to the test
Symptom relief Recruiting nowThe aim of the study is to investigate and improve non-pharmacological rehabilitation methods for patients with Complex Regional Pain Syndrome (CRPS) to reduce pain and restore work and functional capacity to lower overall treatment costs. Current treatment methods offer limited …
Phase: NA • Sponsor: Oulu University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New hope for breast cancer patients who stopped responding to standard therapy
Disease control Recruiting nowThis is a prospective, single-arm, single-center, Phase II clinical study designed to assess the preliminary efficacy and safety of SKB264 Plus Inetetamab plus inetetamab for the treatment of HER2-positive, unresectable, locally advanced or metastatic breast cancer following prog…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New weekly shot aims to tame type 2 diabetes
Disease control Not yet recruitingThe study is being conducted to evaluate the efficacy and safety of HS-20094 once weekly (QW) in subjects with type 2 diabetes mellitus not adequately controlled with metformin monotherapy or in combination with SGLT2 inhibitors compared to Dulaglutide QW for 44 weeks and 52 week…
Phase: PHASE3 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 13:37 UTC
-
Virtual reality may mimic exercise benefits for sedentary people
Disease control Recruiting nowProlonged sedentary conditions contribute to declining health across human populations and cause significant secondary health consequences for many patients whose illnesses or injuries prevent them from exercising. The investigators have demonstrated that in a small animal fruit …
Phase: NA • Sponsor: Wayne State University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Radiation and immunotherapy join forces against tough pancreatic cancer
Disease control Recruiting nowTo investigate the activating effect of local lesion low-dose radiotherapy (2Gy) on the tumor immune microenvironment, and the efficacy, safety, and feasibility of its combination with pembrolizumab and standard therapy in patients with advanced pancreatic cancer. Concurrently, t…
Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Can friends help find hidden HIV? new trial recruits peers to boost testing
Knowledge-focused Recruiting nowIn South Africa's large generalized HIV epidemic, male-to-female transmission comprises a large proportion of transmission events, but men are much less likely to seek HIV testing, and disproportionately remain undiagnosed. HIV-related stigma is a key barrier to recruiting men to…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Rapid dual test for HIV and syphilis could save newborns in guatemala
Diagnosis CompletedThe purpose of this study is to determine if a strategy utilizing the Chembio HIV/syphilis rapid point-of-care (POC) test for diagnosis of HIV and syphilis in pregnant women attending prenatal clinics in Guatemala will increase screening and detection rates thereby resulting in h…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Brain scans and genes may guide better schizophrenia drug choices
Disease control Recruiting nowThis study is recruiting participants who are experiencing a first episode of psychosis and who have certain genetic factors that may make them respond better to certain medications that are used to treat people with psychosis.
Phase: PHASE4 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug mimics IVIg to fight low platelet disorder
Disease control Recruiting nowThe purpose of the study is to evaluate the safety of NVG-2089 and to evaluate how well patients respond to this investigational treatment. NVG-2089 is a new drug that is being developed for treating patients with ITP. NVG-2089 is designed to mimic the effects of a protein called…
Phase: PHASE2 • Sponsor: Nuvig Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug targets tough KRAS cancers in early trial
Disease control Recruiting nowThe primary purpose of this study is to evaluate the safety, pharmacokinetics, and anti-tumor activity of TLN-372 as a single agent and in combination with other anti-tumor agents, in patients with advanced KRAS mutant solid tumors
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for advanced colon cancer: drug combo trial launches
Disease control Recruiting nowThis is an open-label multicenter, single-arm Phase II study of Fruquintinib in combination with FOLFIRI (leucovorin calcium (folinic acid), fluorouracil, and irinotecan) in participants with metastatic colorectal cancer (mCRC). The main goals of this study are to: * Evaluate th…
Phase: PHASE2 • Sponsor: SCRI Development Innovations, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New rotating catheter aims to unclog leg arteries without major surgery
Disease control Recruiting nowThe XTRACT Registry is a prospective, single arm multicenter study on the use of on the Rotarex(TM) Rotational Excisional Atherectomy System.
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a home-modification program keep stroke patients out of nursing homes?
Disease control Recruiting nowThis study evaluates a program designed to help individuals transition from inpatient rehabilitation to home following an ischemic or hemorrhagic stroke. Half of the participants will receive a stroke education program while the other half will receive an environmental modificati…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New cocktail of cancer drugs targets Hard-to-Treat head and neck tumors
Disease control Recruiting nowThis Phase I clinical trial evaluates the safety, tolerability, and optimal dosing of Zanzalintinib in combination with Pembrolizumab and Cetuximab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M HNSCC). The study aims to establish t…
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Zapping breathing muscles may speed ventilator weaning
Symptom relief CompletedThis trial evaluates whether transcutaneous diaphragmatic/phrenic nerve stimulation (TEDS), abdominal functional electrical stimulation (abFES), or their combination, accelerates and improves the quality of weaning from prolonged invasive mechanical ventilation (IMV), compared wi…
Phase: NA • Sponsor: Capital Medical University • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New hope for lymphoma patients: glofitamab studied in Real-World setting
Disease control Recruiting nowThis study will investigate how well glofitamab-based therapy works and how safe it is in Chinese adult participants with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).
Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New eye implant could ease glaucoma pressure
Disease control Recruiting nowThis is a prospective, multi-center, international, cohort expansion study. Part 1 will be conducted in subjects with open angle glaucoma to identify the best insertion tool for MINIject S+. In Part 1, three different investigational insertion tools will be used to place MINIject…
Phase: NA • Sponsor: iSTAR Medical • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Tailored cocktail of exercise, supplements, and drugs aims to slow aging
Disease control Recruiting nowAs the population ages, the growing prevalence of age-related diseases is creating substantial challenges for healthcare systems worldwide. Current therapeutic strategies often target individual diseases and decrease mortality without improving healthspan. The geroscience hypothe…
Phase: NA • Sponsor: National University of Singapore • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug trial aims to tame chronic lung infections
Disease control Recruiting nowThis is a phase III, single-arm, open-label, multicenter study to assess the safety of HSK31858 in non-cystic fibrosis bronchiectasis (NCFBE) participants.
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC